Agenus Inc. (AGEN) Financials

AGEN Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 313.9 million 462.3 million
2023-09-30 335.5 million 450.8 million
2023-06-30 383.6 million 460.4 million
2023-03-31 412.9 million 466.0 million

AGEN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -35.2 million 5.5 million
2023-09-30 -68.7 million 5.9 million
2023-06-30 -48.9 million 6.0 million
2023-03-31 -60.4 million 5.5 million

AGEN Net Income

No data available :(

AGEN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 76.1 million - 65.1 million
2023-09-30 106.3 million - 75.9 million
2023-06-30 157.9 million - 74.1 million
2023-03-31 189.2 million 12.6 million 74.1 million

AGEN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 394.4 million
2023-09-30 378.2 million
2023-06-30 351.4 million
2023-03-31 317.1 million

AGEN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 5.2 million 66.7 million 21.2 million 5.2 million
2023-09-30 3.5 million 3.4 million 18.9 million -
2023-06-30 4.4 million 2.5 million 20.4 million -
2023-03-31 1.8 million 2.6 million 18.2 million -

AGEN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 83.8 million 5.5 million
2023-09-30 24.3 million 51.7 million
2023-06-30 25.3 million 59.5 million
2023-03-31 22.9 million 59.4 million

AGEN

Price: $11.69

52 week price:
4.97
42.60

Payout Ratio Range:
-71.48%
-38.36%

Earnings Per Share: -12.67 USD

P/E Ratio: -0.94

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 207310

Ebitda: -30.2 million

Market Capitalization: 185.9 million

Links: